<DOC>
	<DOCNO>NCT00553943</DOCNO>
	<brief_summary>The purpose study measure rate complete response ( CR UCR ) end course immuno-chemotherapy : - cerebral radiotherapy PCL - course immuno-chemotherapy aggressive lymphoma neuromeningeal involvement Toxicity protocol Overall survival Survival without relapse Long-term incidence neurocognitive toxicity</brief_summary>
	<brief_title>Phase II Study Evaluate Combination Rituximab DepoCyte® C5R Chemotherapy Protocol Patients Between Ages 18 60 Years With Primary Cerebral Non-Hodgkin Lymphoma Systemic Diffuse Large B-cell Lymphoma With Neuromeningeal Invasion Diagnosis</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , Non-Hodgkin</mesh_term>
	<mesh_term>Lymphoma , B-Cell</mesh_term>
	<mesh_term>Lymphoma , Large B-Cell , Diffuse</mesh_term>
	<mesh_term>Rituximab</mesh_term>
	<mesh_term>Cytarabine</mesh_term>
	<criteria>Primary cerebral oculocerebral NHL previously treat chemotherapy radiotherapy diffuse large Bcell lymphoma , cerebral / neuromeningeal involvement diagnosis . Diagnosis prove histological cytological examination cerebral specimen , CSF vitreous humour . Diffuse large cell CD20+ lymphoma . Men woman age 18 60 year . Presence measurable target evaluate response . Negative serological test HIV , hepatitis B ( except case vaccination ) , hepatitis C. Lifeexpectancy ≥ 3 month Patient give write consent participate study . CD20 lymphoma . History indolent lymphoma , treat untreated . Contraindication one product use polychemotherapy . Known hypersensitivity mouse antibody . Absence measurable target evaluate response . History cancer 5 year prior inclusion except cutaneous basocellular carcinoma noninvasive carcinoma neck uterus . Cardiac contraindication treatment anthracyclines hyperhydration : SEVERE DISTURBANCE OF HEART RHYTHM VENTRICULAR EJECTION FRACTION BELOW 50 % HISTORY OF RECENT MYOCARDIAL INFARCTION Previously know severe renal insufficiency and/or creatinaemia &gt; 150 µM/L ( apart invasion kidney lymphoma ) . Total bilirubin &gt; 30 µmol/L , ASAT , ALAT &gt; 2.5 time upper normal value ( apart invasion liver lymphoma ) . Insufficient medullary reserve : PNL &lt; 1 G/L platelet &lt; 100 G/L ( apart invasion medulla lymphoma ) . History organ transplantation cause severe immunosuppression . Pregnant woman . Patient incapable keep regular monitoring .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>October 2010</verification_date>
	<keyword>lymphoma</keyword>
	<keyword>cerebral lymphoma</keyword>
	<keyword>central nervous system</keyword>
	<keyword>cytarabine</keyword>
	<keyword>rituximab</keyword>
	<keyword>Diffuse large B-cell lymphoma , cerebral neuromeningeal involvement</keyword>
</DOC>